Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2017-10-06 2017-03-13
Drug Identification Number 02268140 02268140
Brand name BRAVELLE BRAVELLE
Common or Proper name BRAVELLE BRAVELLE
Company Name FERRING INC FERRING INC
Ingredients Urofollitropin for injection Urofollitropin for injection
Strength(s) 75 IU's per vial 75 IU's per vial
Dosage form(s) Powder for Injection Powder for Injection
Route of administration Subcutaneous Subcutaneous
Packaging size 5 vials 5 vials
ATC code G03GA G03GA
ATC description GONADOTROPHINS AND OTHER OVULATION STIMULANTS GONADOTROPHINS AND OTHER OVULATION STIMULANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2015-09-09
Actual start date 2015-10-01 2015-10-01
Estimated end date Unknown 2018-06-01
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments